Abstract:Introduction: The FOXC2 transcription factor has been tied to a wide range of disease states, serving as a promising prognostic biomarker associated with aggressive basal-like human breast cancers (increased cancer invasion and metastasis). Dysregulation of FOXC2 expression has also been found to promote defects in lymphatic remodeling and hyperplastic lymphedema-distichiasis (LD). Since chronic lymphedema is a forerunner of several malignancies and cancers have been known to arise from poorly healing chronic wounds (e.g., Marjolin ulcers), we examined the effect of Foxc2 dysfunction on skin wound healing. Methods: We used our splinted excisional wounding model that mimics human-like wound healing on wildtype and Foxc2 +/− mice (n = 4), which demonstrate incomplete lymphatic vasculature and lymphatic dysfunction. Wound size was measured over the course of 18 days. Tissue was explanted from both groups at post-operative day (POD) 14 and 18 and stained with Masson's Trichrome to assess scar formation, Picrosirius Red for dermal integrity, or immunofluorescence to assess lymphatic (LYVE1) cell populations. Results: Wildtype mice completely healed by POD 14, while Foxc2 +/− mice did not completely heal until POD18. Scar area of healed Foxc2 +/− mice (POD 18) was larger than that of healed wild-type mice (POD 14; p = 0.0294). At POD 14, collagen "bers in the scars of Foxc2 +/− mice to be narrower ( p = 0.0117) and more highly aligned ( p = 0.0110), indicating signi"cantly more "brosis in these mice. Collagen "bers in both groups became longer ( p = 0.0116) and wider ( p = 0.0020) from POD 14 to 18, indicating a temporal evolution of "brosis. Foxc2 +/− mice also had lower numbers of LYVE1+, F4/80+ and CD4+ cells compared to wildtype mice. Discussion: Individuals over 65 years old are more likely to develop cancer and are highly susceptible to developing chronic wounds. Here, we found that FOXC2, which is tied to cancer metastasis and lymphatic dysregulation, also impairs wound healing and promotes "brotic tissue architecture. With FOXC2 proposed as a potential therapeutic target for cancer metastasis, its downstream systemic effects should be considered against the increased chance of developing nonhealing wounds. Further delineation of the microenvironment, cellular events, and molecular signals during normal and Foxc2-associated abnormal wound healing will improve clinical therapies targeting this important marker.

Foxc1 and Foxc2 Deletion Causes Abnormal Lymphangiogenesis and Correlates with ERK Hyperactivation.

Shear stimulation of FOXC1 and FOXC2 differentially regulates cytoskeletal activity during lymphatic valve maturation.

Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition

Foxo1 Deletion Promotes the Growth of New Lymphatic Valves

Foxc2 Transcription Factor: A Novel Regulator of Lymphangiogenesis

FOXC2 controls adult lymphatic endothelial specialization, function, and gut lymphatic barrier preventing multiorgan failure

Cancer and lymphatic marker FOXC2 drives wound healing and fibrotic tissue formation

Lymphatic Endothelial Cells, Lymphedematous Lymphangiogenesis, and Molecular Control of Edema Formation

Genetic Landscape of FOXC2 Mutations in Lymphedema-Distichiasis Syndrome: Different Mechanism of Pathogenicity for Mutations in Different Domains

Down-regulation of Polycystin in Lymphatic Malformations: Possible Role in the Proliferation of Lymphatic Endothelial Cells.

Temporal and spatial regulation of epsin abundance and VEGFR3 signaling are required for lymphatic valve formation and function.

Pharmacological Inhibition of FOXO1 Promotes Lymphatic Valve Growth in a Congenital Lymphedema Mouse Model

Lymphatic endothelial cell-specific NRAS p.Q61R mutant embryos show abnormal lymphatic vessel morphogenesis

The mechanosensory channel PIEZO1 functions upstream of angiopoietin/TIE/FOXO1 signaling in lymphatic development

FOXC1 and FOXC2 Ablation Causes Abnormal Valvular Endothelial Cell Junctions and Lymphatic Vessel Formation in Myxomatous Mitral Valve Degeneration

Temporospatial inhibition of Erk signaling is required for lymphatic valve formation

Therapeutic Efficacy of ECs Foxp1 Targeting Hif1α-Hk2 Glycolysis Signal to Restrict Angiogenesis

Therapeutic Efficacy of ECs Foxp1 Targeting Hif1α-Hk2 Α-Hk2 Glycolysis Signal to Restrict Angiogenesis

A Critical Role of VEGFR2 in Lymphatic Tumor Metastasis

Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression

Lymphatic Defects in Zebrafish sox18 Mutants Are Exacerbated by Perturbed VEGFC Signaling, While Masked by Elevated sox7 Expression